Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway (Clinical Epigenetics, (2018), 10, 1, (64), 10.1186/s13148-018-0495-y)

Following publication of the original article [1], the authors noticed the errors in Fig. 4b and Fig. S4A in the supplementary material. The revised Fig. 4 has been presented with this erratum and the revised supplementary material with the inclusion of new Fig. S4A has been uploaded.